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ABSTRACT
Objectives: The purposes of the present study were 1) to systematically review the literature on the surgical non-regenerative 
treatments of peri-implantitis and 2) to determine a predictable therapeutic option for the clinical management of peri-
implantitis lesions.
Material and Methods: The study search was performed on primary database MEDLINE and EMBASE from 2005 until 
2016. Sequential screenings at the title, abstract, and full-text levels were performed. Clinical human studies in the English 
language that had reported changes in probing depth (PD) and/or bleeding on probing (BOP) and/or radiologic marginal 
bone level changes after peri-implantitis surgical non-regenerative treatment at 6-month follow-up or longer were included 
accordingly PRISMA guidelines. 
Results: The first electronic and hand search resulted in 765 citations. From 16 full-text articles reviewed, 6 were included 
in this systematic review. Surgical non-regenerative methods were found to be efficient in reducing clinical parameters. BOP 
and PD values were significantly decreased following implantoplasty and systematic administration of antibacterials, but not 
after local application of chemical compounds or diode laser. Similarly, significant improvement in clinical and radiographic 
parameters was found only after implantoplasty compared with resective surgery alone. We found significant heterogeneity 
in study designs and treatments provided among the pooled studies. All of the studies revealed an unclear or high risk of bias.
Conclusions: Surgical non-regenerative treatment of peri-implantitis was found to be effective to reduce the soft tissue 
inflammation and decrease probing depth. More randomized controlled clinical trials are needed to assess the efficacy of 
surgical non-regenerative therapy of peri-implantitis.
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INTRODUCTION
Over the last decades, the use of dental implants has 
become a standard treatment option to replace missing 
or hopeless teeth. Several longitudinal studies have 
reported high survival rates for implants placed, 
over a period of 10 years [1,2]. Despite of these 
encouraging data for the use of dental implants in oral 
rehabilitation, clinicians shell consider several types 
of complications that may be encountered. Plaque-
induced peri-implantitis is considered one of the most 
common biological complication [3]. Peri-implantitis 
can be defined as a clinical condition characterized by 
an inflammatory reaction that involves the hard and 
soft tissue, with pathological pocket formation and 
loss of supporting bone around osseointegrated dental 
implants [4,5].
Bacteria accumulation on the implant surface plays 
an important role in the aetiology of peri-implantitis 
[6]. The microorganisms essential for the development 
of infections around dental implants seems similar 
to the bacteria that cause periodontal diseases. 
However, recent data pointed to the presence of also 
very specific microorganisms [7]. The sub marginal 
plaque contains a large variety of Gram-negative 
anaerobic rods, fusiform bacteria, motile and curved 
rods as well as spirochetes [8] and large amounts of 
densely packed inflammatory cells that frequently 
accompanied by a crater-like bone defect surrounding 
the implant [9,10]. The treatment of peri-implantitis 
thus aims to arrest the progression of the disease by 
an anti-inflammatory therapy in order to prevent the 
progressive loss of supporting bone. Thereafter, peri-
implant tissues can be re-established and the healthy 
soft and hard tissues maintained [11]. Actually, 
many endosseous implants may be successfully 
used as prosthetic abutments in fully and partially 
edentulous patients for a prolonged period of time 
[5]. Nevertheless, numerous aetiological factors may 
play a decisive role for the progress of infection. The 
micro and macro design of the implant, the abutment 
connection, the passive adjustment of the prosthesis 
and the excessive mechanical load are all related with 
the disease [12].
Several clinical protocols for treatment of peri-
implantitis have been proposed, including mechanical 
debridement, the use of antiseptics and local or 
systemic antibiotics [13-15], surgical access [16,17], 
and regenerative [18-20] or resective surgical 
procedures [21-23]. However, the currently available 
evidence does not provide any firm or specific 
recommendations for the surgical therapy of peri-
implantitis [24]. A recent meta-analyses confirmed 
that it’s possible to obtain a significant reduction in 
radiological peri-implant marginal bone level using 
either treatment approaches [25]. The treatment of 
peri-implant bone loss is thus quite challenging for the 
clinician.
The purpose of this review is to screen the recent 
literature on surgical non-regenerative treatment 
of peri-implantitis. The effectiveness of various 
surgical non-regenerative treatment modalities was 
evaluated in relation to the resolution of different 
clinical and radiographic parameters. Accordingly, 
this review may help clinicians in the selection of the 
most appropriate surgical non-regenerative treatment 
modality.
MATERIAL AND METHODS
Protocol and registration
The review was registered in PROSPERO, an 
international prospective register of systematic 
reviews under number CRD42016043320. The 
methods of the analysis and inclusion criteria were 
specified in advance and documented in a protocol, 
accessible through the following link:
http://www.crd.york.ac.uk/PROSPERO/display_
record.asp?ID=CRD42016043320
The reporting of this systematic analysis adhered to 
the Preferred Reporting Items for Systematic Review 
and Meta-Analyses (PRISMA) statement [26].
Focus question
The following focus question was developed 
according to the population, intervention, comparison, 
and outcome (PICO) study design: what are 
the overall treatment outcomes of surgical non-
regenerative procedures applied in the treatment of 
peri-implantitis lesions?
Types of publications
The review included clinical studies in humans 
published in English language. Letters, editorials, 
case reports, literature reviews, and PhD theses were 
excluded. 
Types of studies
The review included all human prospective and 
retrospective studies and clinical trials, cohort studies, 
case-control studies, and case series studies published 
between January 2005 and January 2016, on surgical 
non-regenerative treatment of peri-implantitis.
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Information sources
The search strategy for relevant studies comprised 
the evaluation of electronic databases including 
Ovid MEDLINE, PubMed, EMBASE and Dentistry 
and Oral Sciences Source published in the English 
language. A supplementary hand search of the 
reference lists performed in dental and implant-related 
journals limited to English language was carried out 
to source additional relevant publications for the 
same time period in following journals: 1) “Journal of 
Periodontology”; 2) “Clinical Implant Dentistry and 
Related Research”; 3) “International Journal of Oral 
and Maxillofacial Implants”; 4) “Clinical Oral Implants 
Research”; 5) “Implant Dentistry”; 6) “International 
Journal of Oral and Maxillofacial Surgery”; 7) “Journal 
of Oral and Maxillofacial Surgery”; 8) “Journal of 
Dental Research; 9) “Journal of Prosthetic Dentistry”; 
10) “International Journal of Prosthodontics”; 
11) “Journal of Oral Implantology”; 12) “Journal 
of Clinical Periodontology”; 13) “International 
Journal of Periodontics & Restorative Dentistry”; 
14) “European Journal of Oral Implantology”. 
Search
The keywords used in the search of the selected 
electronic databases included the following: “peri-
implantitis” OR “periimplantitis” OR “peri-implant” 
OR “periimplant” or (“implant” AND “failure”) AND 
“surgical” OR “treatment” OR “therapy” OR “non-
regenerative” OR “nonregenerative” OR “laser” OR 
“lasers”. The choice of keywords was intended to be 
extensive to collect as much relevant data as possible 
and to refine the search results, without relying on 
electronic means alone.
Selection of studies
The resulting articles were revised by two 
independent reviewers to ascertain the inclusion 
and exclusion criteria, compare their decisions and 
resolve possible differences through discussion. 
An experienced senior reviewer was consulted 
when consensus could not be reached. The level of 
agreement between the reviewers regarding study 
inclusion was calculated using κ statistics. At the 
title and abstract stage, one reviewer accepted the 
citations that appeared to meet inclusion criteria and 
send them to full-text review, with a second reviewer 
assessing only those citations and abstracts that the 
first reviewer deemed ineligible. Consequently, a 
complete independent dual review of full-text articles 
was undertaken.
Disease definition
The authors of this review classified peri-implantitis 
in all cases where there was a clear radiographic 
threshold > 2 mm of continuous marginal bone loss 
beyond biologic peri-implant bone remodelling, 
presence of bleeding on probing (BOP) and/or 
suppuration on probing with probing depth (PD) more 
than 6 mm [3]. 
Inclusion and exclusion criteria
The full text of all studies of possible relevance 
was obtained for assessment against the following 
inclusion criteria:
• Investigated surgical non-regenerative treatment 
in patients with at least one osseointegrated 
screw-shaped dental implant, that presented signs 
of peri-implantitis;
• Studies involving at least one surgical non-
regenerative treatment method of peri-implantitis; 
• All human prospective or retrospective follow-
up studies and clinical trials, cohort studies, 
case-control studies, and case series studies 
with a minimal sample size of 10 implants and a 
minimum 6 months of follow-up period;
• Report on clinical and radiographic peri-implant 
tissues changes, including PD and/or BOP as 
primary outcome measure and/or radiographic 
bone level (RBL) change as secondary outcome 
measure.
The applied exclusion criteria for studies were as 
follows:
•	 In	vitro and in	vivo studies;
• Studies involving patients with specific systemic 
diseases, immunologic disorders, uncontrolled 
diabetes mellitus, osteoporosis, or other implant 
risk related systemic conditions;
• Studies investigating ceramic or coated implants 
surface;
• Insufficient information regarding the selected 
topic;
• Non accessible relevant data, such as 
impossibility to contact the authors for any 
reason.
Sequential search strategy
All article titles were screened to eliminate irrelevant 
publications considering the exclusion criteria. Next, 
some studies were excluded based on data obtained 
after reading the abstracts. At the final stage, the full 
texts were screened based on the inclusion criteria to 
confirm the eligibility of each study.
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Data extraction
The data were extracted and collected from included 
studies in the form of variables. According to the 
aim of the present review, the data were arranged as 
follows:
• “Author (Year)” - revealed the author and year of 
publication.
• “Type of study” - indicated the type of the study.
• “Sample size” - described the number of patients 
examined.
• “Detoxification method” - described additional 
implant surface detoxification measures applied 
in addition to the instrumental debridement and 
degranulation.
• “Antimicrobial” - described antimicrobial agents 
(e.g. systemic antibiotics, chlorhexidine mouth 
rinse) used adjunctive to the surgery.
• “Probing depth change (ΔPD)” - described PD 
difference (in mm) before and after surgical 
treatment.
• “Bleeding on probing change (ΔBOP)” - 
described BOP difference (in %) before and after 
surgical treatment.
• “Radiologic bone level change (ΔRBL)” - 
described the marginal bone level difference 
(in mm; measured from implant shoulder to the 
bone surface) before and after the treatment; 
and/or intrabony defect depth difference (in 
mm; measured from the bottom of the defect 
to the interproximal bone) before and after 
treatment. 
• “Follow-up” - described the duration of the 
observed outcomes.
Risk of bias assessment
The risk of bias was assessed independently and in 
duplicate by the two authors during the data extraction 
process, using the Cochrane Collaboration’s two-part 
tool for assessing risk of bias [27]. The following 
possible sources of bias were addressed: random 
sequence generation (selection bias); allocation 
concealment (selection bias); blinding of participants 
and personnel (performance bias and detection bias); 
incomplete outcome data (attrition bias); selective 
reporting (reporting bias) and other bias (examiner 
blinding, examiner calibration, standardized probing 
force, and standardized radiographic assessment). The 
authors’ judgment for each source of bias item was 
assigned for each study in the data extraction table 
(Table 1). An overall risk of bias was then assigned to 
each trial according to Higgins et al. [27]. The degrees 
of bias were categorized as: (1) low risk, if all the 
criteria were met; (2) moderate risk, when only one 
criterion was missing; (3) high risk, if two or more 
criteria were missing and (4) unclear risk, if too few 
details were available to make a judgement of certain 
risk assessment.
RESULTS
Study selection
Article review and data extraction were performed 
according to the PRISMA flow diagram (Figure 1). 
The initial search displayed 765 results from the 
MEDLINE (NCBI PubMed and PMC) and EMBASE 
databases and 3 results from other sources. A total 
of 768 search results were initially screened. The 
inclusion and exclusion criteria were applied to 16 
full-text articles. 
The κ value for inter-reviewer agreement for 
potentially relevant articles was 1 (titles and abstracts) 
and > 0.9 (full-text articles), indicating a “very good” 
agreement between the 2 reviewers, according to the 
criteria of Landis and Koch [28].
Study exclusion
Ten studies were excluded after full-text 
assessment, being a review paper (n = 7) and due to 
methodological and design faults (n = 3).
Study characteristics
Finally, 6 articles were included in the review 
[16,17,21-23,29]. The summarized individual study 
characteristics are described in Table 2. A total of 150 
patients diagnosed with peri-implantitis were treated 
in the included studies using different surgical non-
regenerative methods. 
From the included studies, two were prospective 
randomized controlled trials [17,22,23], one 
was prospective cohort study [16] and two were 
retrospective controlled studies [21,29]. One study 
included a follow-up period of 6 months [17], three 
of 1 year [16,21,29] and two up to 3 years [22,23]. 
The mean reported age of the patients ranged from 55 
[17] to 61.5 years [21]. 
All studies included rough surface dental implants. 
A total of 14 implants treated with respective surgery 
were lost [21,29]. Due to the persisting inflammation, 
15 implants had to be removed following resective 
surgery [21-23]. One implant was removed due to the 
fracture of the implant neck [29].
Four studies reported on smoking status of the 
patients, ranging from 25% [16] to 59.1% [29]. 
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Table 1. Descriptive information of the included studies
Study Year of publication
Type of 
study
Implant 
surface Treatment method used Sample size Smokers
Follow-up
(months)
PD changes 
Mean (SD)
BOP changes
Mean (SD)
Radiographic marginal bone level changes/
bone defect fill Comments
Heitz-Mayfield et 
al. [16] 2012
Prospective 
cohort study
36 implants,
rough
Open flap debridement and 
implant surface decontamination 
with saline and with adjunctive 
systemic amoxicillin and 
metronidazole
24 patients; 
mean age 56 0.25 12
Baseline:
mean PD ≥ 6 mm: 20%;
5 ≤ PD < 6 mm: 25%;
4 ≤ PD < 5 mm: 28%;
< 4 mm: 7%.
After 12 months: 
 ≥ 6 mm: 0%;
5 ≤ PD < 6 mm: 0%;
4 ≤ PD < 5 mm: 11%;
< 4 mm: 89%.
Statistically significant (P < 0.01) reduction in 
mean PD.
Number of sites with BOP:
- baseline: 2.5 (1);
- after 12 months: 1 (1.2).
Statistically significant (P < 0.01) reduction in 
BOP.
Three implants in 3 patients had 0.6 - 1 mm 
bone loss at 12 months. 
Three implants in 3 patients showed bone 
gain, while the remaining implants had stable 
marginal bone levels.
Access flap surgery in combination 
with systemic antibiotics was an 
effective treatment resulting in 
significantly reduced BOP and PD 
scores.
Papadopoulos et 
al. [17] 2015
Randomized 
controlled 
clinical study
Not known
Group 1: open flap debridement 
alone.
Group 2: open flap debridement 
with the additional use of a diode 
laser for the treatment of peri-
implantitis.
16: age 55. 
(40 - 73)
Group 1: 8
Group 2: 8
Not known 6
Group 1:
- baseline mean PD 5.92 mm;
- after 6 months 4.44 mm;
- reduction of 1.38 mm.
Group 2:
- baseline mean PD 5.52 mm;
- after 6 months 4.31 mm;
- reduction of 1.19 mm.
No statistically significant difference between 
the 2 groups.
Group 1:
- baseline 93.5%;
- after 6 months 31.3%;
- mean reduction 72.9%.
Group 2:
- baseline 81.2%;
- after 6 months 23.8%;
- mean reduction 66.7% (P < 0.05).
No statistically significant difference between 
groups.
Surgical treatment of peri-implantitis 
by access flap surgery resulted in 
improvement of clinical parameters.
The additional use of a diode laser did 
not have any extra beneficial effect.
de Waal et al. [21] 2013 Retrospective clinical study
79 implants, 
rough
Resective surgery with bone 
recontouring and surface 
decontamination.
Group 1: 0.12% CHX + 0.05% 
CPC.
Group 2: placebo.
30:
Group : 15
age 61.5
Group 2: 15
age 59.4
46.7 12
Mean PD ≥5 mm:
Group 1:
- baseline 88.2 (18.4)%;
- after 12 months 733.9 (39)%.
Group 2:
- baseline 75.2 (26.1)%;
- after 12 months 17.1 (24)%
Group 1:
- baseline 87.1 (27)%;
- after 12 months 25.8 (8)%.
Group 2:
- baseline 81.3 (39)%;
- after 12 months 15.8 (6)%.
Mean MBL:
Group 1:
- baseline 4.3 (2.1) mm;
- after 12 months 5 (2.5) mm.
Group 2:
- baseline 3.61 (1.9) mm;
- after 12 months 3.9 (2) mm.
Improved clinical parameters (eg, BOP 
and PD) and MBL compared with the 
baseline were observed in both groups, 
with no significant difference between 
them.
Mean PD ≥ 6 mm:
Group 1:
- baseline 54.5 (33.7)%;
- after 12 months 17.7 (34.3)%.
Group 2:
- baseline 46.9 (33.7)%;
- after 12 months 17.2 (19.2)%.
Romeo et al. [22] 2005 Randomized clinical study
35 implants, 
rough
Group 1 (test): resective surgery 
and modification of surface 
topography (implantoplasty).
Group 2: resective surgery only 
(control group).
17:
Group 1: 10
Group 2: 7
29 36
Group 1: 
- baseline 5.79 (1.69) mm; 
- after 36 months 3.21 (0.56) mm 
(Student’s t-value of +11.63).
Group 2: 
- baseline 6.52 (1.62) mm; 
- after 24 months 5.5 (1.47) mm 
(Student’s t-value of +3.18).
Mean bleeding index:
Group 1:
- baseline 2.83 (0.47);
- after 36 months 0.61 (0.67)
(Student’s t-value of +16.02).
Group 2:
- baseline 2.86 (0.35);
- after 24 months 2.33 (0.75)
(Student’s t-value of +3.33).
Clinical parameters improved in both 
treatment groups, without a significant 
difference between them.
Romeo et al. [23] 2007 Randomized clinical study
38 implants, 
rough
Group 1 (test): resective surgery 
and implantoplasty.
Group 2 (control): resective 
surgery alone.
19:
Group 1: 10
Group 2: 9
Not 
reported 36
Group 1:
- baseline mesially 3.82 (1.52) mm, distally 
3.94 (1.64) mm;
- after 3 years mesially 3.81 (3.94) mm, distally 
1.72 (1.79) mm.
Group 2:
- baseline mesially 3.45 (1.93) mm, distally 
3.49 (1.8) mm;
- after 3 years mesially 5.35 (1.99) mm, distally 
5.42 (1.91) mm
Significantly higher (P < 0.05) mean MBL was 
recorded in group 2 than in group 1.
A significantly extended MBL 
was reported in the group without 
implantoplasty.
de Waal et al. [29] 2015 Retrospective clinical study
108 implants,
rough
Resective surgery with bone 
recontouring and surface 
decontamination.
Group 1: 0.2% chlorheksidine 
solution.
Group 2: 0.12% CHX + 0.05% 
CPC.
44:
Group 1: 22 
age 60.5
Group 2: 22 
age 58.6
59.1 12
Mean PD ≥ 5 mm:
Group 1: 
- baseline 57.5 (26.6)%; 
- after 12 months 7.3 (12.6)%.
Group 2: 
- baseline 60.2 (28.3)%; 
- after 12 months 5.3 (12.5)%.
Group 1:
- baseline 82.1 (23.9)%;
- after 12 months 42.7 (34.2)%.
Group 2:
- baseline 74.2 (27.8)%;
- after 12 months 37.0 (35.3)%.
No significant difference between the groups 
(P = 0.6).
Mean MBL:
Group 1:
- baseline 4 (1.5) mm;
- after 12 months 4.3 (1.7) mm.
Group 2:
- baseline 4.1 (1.6) mm;
- after 12 months 4.1 (1.7) mm.
Radiologic bone loss was not significantly 
different between the groups (P = 0.8).
Improved clinical parameters (e.g. BOP 
and PD) and MBL compared with the 
baseline were observed in both groups, 
with no significant difference between 
them.
Mean PD ≥ 6 mm:
Group 1: 
- baseline 29.1 (31.6)%; 
- after 12 months 2.1 (7)%.
Group 2: 
- baseline 34.4 (31.8)%; 
- after 12 months 1.4 (5.8)%.
No significant difference between the groups 
(P = 0.6).
CPC = Cetylpyridinium chloride; CHX = chlorhexidine; MBL = marginal bone loss; PD = probing depth; BOP = bleeding on probing.
http://www.ejomr.org/JOMR/archives/2016/3/e14/v7n3e14ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol. 7 | No 3 | e14 | p.6
(page number not for citation purposes)
JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH                                                     Ramanauskaite et al.
Figure 1. PRISMA flow diagram.
Table 2. Assessment of the risk of bias 
Author
Random 
sequence 
generation
Allocation 
concealment Blinding
Incomplete 
outcome 
data
Selective 
reporting
Other 
bias
Heitz-Mayfield et al. [16] ? ? ? - - -
Papadopoulos et al. [17] + ? + + ? +
de Waal et al  [21] + + + + - +
Romeo et al. [22] - - - + - +
Romeo et al. [23] - - - + - +
de Waal et al. [29] + + + + - +
+ = low risk; ? = unclear risk; - = high risk.
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The study of Heitz-Mayfield et al. [16] showed no 
negative effect of smoking on treatment outcome. 
Smoking was, however, relevant for treatment success 
when for the crude model adjusted for the baseline 
and time, but not when adjusted for baseline, time 
smoking, dental status, history of periodontitis and 
implant surface roughness [21,29]. 
An improvement in peri-implant clinical parameters 
was found in four studies using access flap surgery 
only [17,21-23], surface decontamination with 
chlorhexidine (CHX) and/or cetylpyridinium 
chloride (CPC) [21,29] and systemic antibiotics 
[16]. Significant decrease in BOP scores was showed 
in studies reporting implantoplasty [22] or use of 
systemic antimicrobials [16], but not by using CHX 
with CPC [21,29] or diode laser [17]. Similarly, a 
significant improvement in PD scores resulted with 
the addition of implantoplasty [22] or systemic 
antimicrobials [16], but did not by using the CHX 
with CPC [21,29] or the diode laser [17].
Initial radiologic bone defect depth was measured 
in four studies; in three studies the distance was 
measured from the implant shoulder to the first bone 
contact [21,23,29] or using landmarks as the threads 
of the implants [16]. The mean peri-implant bone 
level at basement ranged from 3.45 mm [23] to 4.1 
mm [29]. Stable peri-implant bone level was found 
following systemic application of antibiotics [16] or 
local use of chemical compounds [21,29]. 
The addition of chemical compounds [21,29] or diode 
laser [17] showed no difference in clinical parameters 
compared to mechanical debridement. On the other 
hand, implantoplasty demonstrated significant 
improvement in clinical and radiographic parameters 
compared to mechanical debridement alone [22,23].
Risk of bias across studies
Summarizing the risk of bias for each study, 4 studies 
were classified as unclear risk (of bias for 1 or more 
key domains) [16,17,23] and two studies were judged 
to have a high risk (of bias for more than 1 domain) 
[21,22]. The risk of bias assessment for the included 
studies is summarized in Table 1.
DISCUSSION
Present review aimed to assess the overall treatment 
outcome of surgical non-regenerative procedures 
applied in the treatment of peri-implantitis lesions. 
The surgical non-regenerative treatment is a relatively 
simple procedure, but it depends on various multiple 
factors including patient general health condition, 
oral hygiene habits, defect configuration, implant 
surface characteristics, decontamination procedure, 
postoperative maintenance program, and various other 
factors that are not possible to fit within the frames 
of systematic literature review and meta-analysis. 
Hereby, we included studies reporting the clinical and/
or radiological outcomes of different surgical non-
regenerative treatment methods. Our findings suggest 
that the effectiveness of peri-implantitis treatment 
using different surgical non-regenerative modalities 
is restrained. Reduction of signs of inflammation 
(decreased BOP index and reduced PD) could be 
expected and the arrest of continuous bone loss may 
be expected. 
Present findings resemble the statement of the Third 
European Association for Osseointegration Consensus 
Conference [30], which claims that peri-implantitis 
respond well to the surgical non-regenerative 
treatment, whereas the mechanical debridement alone 
has limited efficacy. Carbon fiber and/or titanium 
curettes for debridement are recommended as they 
cause minimal damage to implant surfaces [31], 
but the decontamination of the implant surface is 
considered mandatory for the successful treatment. 
Different methods were suggested including chemical, 
mechanical and laser decontaminations [32], aiming 
the elimination of bacteria and the creation of an 
implant surface favourable to bone regeneration and 
re-osseointegration [33]. According to the in	 vitro 
study, airflow devices using glycine powders were 
shown to constitute an efficient therapeutic option for 
the debridement of implants in peri-implantitis defects 
[34]. However, we didn’t found any study related with 
the use of airflow devices in surgical non-regenerative 
surgery. Combined mechanical and chemical removal 
of biofilm from the implant surface is further 
recommended [32]. Chlorhexidine digluconate 
(0.2%) and ethylenediaminetetraacetic acid (24%) 
demonstrated a considerable decontamination capacity 
with respect to killing as well to the removal of 
biofilm cells [35]. The results of the present review 
indicate that the surface decontamination/debridement 
using chlorhexidine digluconate reduce bacterial 
count without significant improvement of the clinical 
parameters [29]. Furthermore, the suppression of 
anaerobic bacteria did not lead to better clinical and 
radiographic outcomes [21].
The majority of surgical protocols include pre-
operative or postoperative systemic antibiotics 
followed by postoperative chlorhexidine rinse. 
The systematic administration of antimicrobials 
in the study of Heitz-Mayfield et al. [16] 
contributed in reducing BOP and PD by surface 
decontamination following open flap debridement. 
http://www.ejomr.org/JOMR/archives/2016/3/e14/v7n3e14ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol. 7 | No 3 | e14 | p.8
(page number not for citation purposes)
JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH                                                     Ramanauskaite et al.
Wohlfahrt et al. [36] prescribed systemic antibiotics 
3 days prior and 7 days after open flap surgery, 
mechanical debridement, decontamination and 
placement of the porous titanium granules. Both 
treatments provided significant clinical improvements 
in PD, but the reconstruction with porous titanium 
granules resulted in better radiographic peri-
implant defect correction. In a recent review, Van 
Winkelhoff [15] found that there is still a need for 
randomized clinical trials on the systematic use of 
antibiotics. Local antibiotic delivery in addition 
to mechanical debridement and irrigation with an 
antimicrobial agent may be effective option for 
treating peri-implantitis lesions [13]. Furthermore, the 
development of bacterial resistance seems to be very 
unlikely even in the event of repeated applications 
[37]. 
The results of Romeo et al. [23] have demonstrated 
the advantage of implantoplasty compared to 
the resective surgery alone in terms of marginal 
bone preservation in cases with advanced peri-
implantitis. The implantoplasty was later applied 
by comparison of Er:YAG laser and saline for 
implant surface decontamination during combined 
resective/regenerative surgery; both decontamination 
methods resulted in significant reduction of BOP 
and clinical attachment level [20]. Subsequently, 
positive effects of implantoplasty without implant 
surface decontamination were confirmed by clinical 
and radiographic parameters using similar treatment 
approach [18]. 
According to the results of this review, the surgical 
treatment approach should be a treatment option in 
cases of evident bone loss and pocket formation over 
5 mm. Nevertheless, it is evident that successful 
peri-implant lesion treatment is a comprehensive 
procedure. The progression of peri-implantitis 
resistent to the treatment may result in implant 
mobility. In such cases, the removal of the implant 
with a successive regenerative procedure is the only 
therapeutic option [18-23]. As the majority of the 
studies reporting on regenerative surgical treatments 
demonstrated significant improvement in clinical 
parameters and intrabony defect fill, one might 
suppose that a regenerative approach should be the 
treatment of choice. Yet, more recently Khoshkam 
et al. [38] stated a lack of evidence to support the 
additional benefit of reconstructive therapy as 
compared to non-reconstructive procedures. 
Oral hygiene instructions and the importance of 
plaque control must be stressed to patients before 
and after the treatment [39]. Nonsurgical subgingival 
mechanical debridement in conjunction with local 
antibacterials, like chlorhexidine digluconate or 
locally delivered antibiotics are effective in reducing 
soft-tissue inflammation [14,40,41] and should be 
the first step in successful treatment. After soft tissue 
health has been achieved and patient’s oral hygiene 
improved, the treatment could be continued with the 
surgical step. The supportive treatment phase, by 
oral hygienists following surgery is an imperative 
as the last step for the success of peri-implantitis 
treatment [20,21]. Serino et al. [42] demonstrated 
that in patients with a high standard of oral hygiene 
and enrolled in a recall system every 6 months, the 
peri-implant conditions obtained following peri-
implant surgery were maintained stable, for the 
majority of subjects and implants, during a 5-year 
period.
Limitations
The evidence of this systematic review was limited to 
randomized, controlled clinical studies. The revised 
studies were relatively of short follow-up period 
and included relatively small numbers of patients. 
The absence of a control group (without treatment 
or placebo) was also a limitation. Finally, there were 
various degrees of heterogeneity in the study design 
and treatment provided among the pooled studies. 
All of the studies included in this review revealed 
an unclear or high risk of bias. The proportion of 
information from studies with unclear or high risk 
of bias may be sufficient to affect the interpretation 
of results [27]. However, the strength of evidence of 
this review is low due to the significant variations 
observed in the included studies.
CONCLUSIONS
The present systematic review revealed that peri-
implantitis treatments using different surgical non-
regenerative modalities are of limited effectiveness. 
It can be concluded that the use of implantoplasty or 
systemic antimicrobials in surgical non-regenerative 
treatment of peri-implantitis lead to a significant 
decrease in bleeding on probing and probing depth. 
Furthermore, the application of chemical compounds 
or diode laser did not result in significant clinical or 
radiographic alterations. Implantoplasty may result in 
improvement in clinical and radiographic parameters 
compared to mechanical debridement alone. There is 
limited evidence that a peri-implant bone level may be 
arrested. Further clinical studies should be conducted 
for the assessment of complex management and the 
efficacy of the maintenance protocol.
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